Colorectal carcinomatosis: a new oncologic frontier
- PMID: 15933477
- DOI: 10.1097/01.cco.0000161746.32511.41
Colorectal carcinomatosis: a new oncologic frontier
Abstract
Purpose of review: In the past, carcinomatosis from colorectal cancer was determined to be a lethal condition with a short survival.
Recent findings: A new treatment strategy starts with cytoreductive surgery in an attempt to remove all visible evidence of cancer implants. Then, chemotherapy is used in the operating room with moderate hyperthermia (41-43 degrees C) in an attempt to eradicate microscopic residual disease. Multiple phase II, a phase III, and a multi-institutional phase II study of 503 patients showed that approximately one-third of these patients can survive long term.
Summary: The expansion of treatment options, including cytoreductive surgery followed by chemotherapy with hyperthermia, to a larger number of patients is appropriate.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
